In breast cancer BMX overexpression promotes proliferation by upregulating the activity of downstream substrates Protease Activated Receptor 1 (PAR1), p21 Activated kinase 1 (PAK1), and Signal Transducer and Activator of Transcription 1 (STAT1; [11]). Here, BMX is linked to breast cancer.